Financial News Search | Sharemaestro Newsreel

20:10 25 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Atara Biotherapeutics (ATRA) director affiliate exercises pre-funded warrants

Funds managed by Redmile Group, LLC, an affiliate of an Atara Biotherapeutics director, exercised pre-funded warrants for ATRA common stock via a cashless exercise on July 22, 2026. This transaction resulted in the funds receiving 195,211 shares, with 60 shares withheld to cover the …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

19:10 25 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Atara Biotherapeutics, Inc. (NASDAQ:ATRA). The lawsuit, filed on behalf of investors who purchased Atara securities between May 20, 2024, and January 9, 2026, alleges that the company made false and misleading statements …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

08:22 25 Jul 2026

MarketBeat Deals and strategy Main company 🇺🇸 United States

Arrowstreet Capital Limited Partnership Buys Shares of 5,161,983 Dynatrace, Inc. $DT

Arrowstreet Capital Limited Partnership has acquired a new stake of 5,161,983 shares in Dynatrace, Inc. (NYSE:DT), valued at approximately $190.89 million, representing 1.73% of the company. Other hedge funds have also adjusted their positions in Dynatrace, with several significantly boosting their holdings. The report …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

08:22 25 Jul 2026

MarketBeat Analyst action Main company 🇺🇸 United States

Dynatrace, Inc. (NYSE:DT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Dynatrace, Inc. (NYSE:DT) has received a consensus "Moderate Buy" rating from thirty brokerages, with an average price target of $49.42. Recent analyst updates include BMO Capital Markets and TD Cowen raising their price targets to $50 with bullish ratings, while Citigroup maintained a buy …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

05:11 25 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

DT|Dynatrace Inc|Price:41.630|Chg%:+0.980

Dynatrace Inc. (DT) is an AI-powered observability platform with healthy fundamentals and high growth potential, currently considered fairly valued. Institutional ownership is very high, and analysts largely rate the stock as "Buy" with a target price of 47.44. The stock is currently trading sideways, …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

03:10 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Dynatrace, Inc. Revenue Breakdown – GETTEX:7DY

Dynatrace, Inc. (GETTEX:7DY) reported total revenue of €1.75 billion last year, with its Subscription segment being the top performer, contributing €1.67 billion. The United States was the primary geographic contributor, accounting for €802.95 million in revenue. The article provides a breakdown of the company's …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

02:40 25 Jul 2026

Investing.com Nigeria Market update Main company 🇺🇸 United States

Form 4 Atara Biotherapeutics Inc For: 24 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Atara Biotherapeutics Inc, referencing the date of July 24. The brief piece includes the stock symbol ATRA and notes a -3.30% change. It appears to be a standard financial markets update on insider …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

00:40 25 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Redmile adjusts Atara Biotherapeutics (ATRA) ownership after warrant exercises

Redmile Group, LLC has updated its ownership in Atara Biotherapeutics (ATRA) through an amended Schedule 13D/A filing, reflecting a beneficial ownership of 950,994 shares, or 9.9% of the outstanding common stock. This adjustment follows a cashless exercise of pre-funded warrants on July 16, 2026, …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

19:41 24 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Atara Biotherapeutics Inc (ATRA) Cash Flow

This article provides a detailed cash flow statement for Atara Biotherapeutics Inc (ATRA), covering numerous quarterly periods. It includes data on operating, investing, and financing cash flows, along with a free cash flow analysis. The page also offers definitions and FAQs regarding cash flow …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

11:41 24 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Siren L.L.C. Purchases 34,771 Shares of Dynatrace, Inc. $DT

Siren L.L.C. increased its stake in Dynatrace, Inc. (NYSE:DT) by 30.2% in the first quarter, acquiring an additional 34,771 shares, bringing its total holding to 150,000 shares valued at approximately $5.55 million. Dynatrace has a consensus analyst rating of "Moderate Buy" with an average …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

06:40 24 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

ATRA|Atara Biotherapeutics Inc|Price:8.089|Chg%:-0.081

Atara Biotherapeutics Inc (ATRA) is an allogeneic T-cell immunotherapy company focused on developing therapies for serious diseases using its Epstein-Barr virus (EBV) T-cell platform. The company's stock shows significant growth potential and is considered fairly valued within the Biotechnology & Medical Research industry, despite …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

22:13 23 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Dynatrace (DT) Stock Looks Cheap On Cash Flow But Rich On Earnings

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Dynatrace stock has had a tough run over the past five years, yet the intrinsic value estimate from a Discounted Cash Flow (DCF) model …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

16:13 23 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Dynatrace (DT) Could Be 47% Below Fair Value Following Its August 5 Earnings Date

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Dynatrace (DT) is in focus after scheduling the release of its first quarter fiscal 2027 results for August 5, 2026, with investors watching how fresh numbers might …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

15:02 23 Jul 2026

Stock Traders Daily Market update Main company 🇺🇸 United States

Avoiding Lag: Real-Time Signals in (ATRA) Movement

This article provides a real-time analysis of Atara Biotherapeutics Inc. (NASDAQ: ATRA) stock movement, highlighting weak sentiment across all horizons supporting a short bias. It details three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis to guide investors. …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

11:11 23 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Globeflex Capital L P Purchases 104,163 Shares of Dynatrace, Inc. $DT

Globeflex Capital L P significantly increased its stake in Dynatrace, Inc. (NYSE:DT) by 391.1% in the first quarter, adding 104,163 shares to own a total of 130,797 shares valued at $4.84 million. Other major institutions also expanded their holdings, with institutional investors now owning …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

08:40 23 Jul 2026

Market source Earnings Main company 🇺🇸 United States

Dynatrace, Inc. (DT) stock price, news, quote and history

This article provides a comprehensive overview of Dynatrace, Inc. (DT) stock, including its current price, historical data, and key financial metrics. It details the company's business activities as an AI-powered observability platform and presents analyst insights, performance comparisons with competitors, and earnings trends. The …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

08:23 23 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Price to sales forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA

This article provides the "Price to sales forward" financial metric for Atara Biotherapeutics, Inc. (NASDAQ: ATRA). It is a finance-related data point from TradingView, which aggregates market data from sources like ICE Data Services and FactSet. The page indicates no current trade activity for …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

23:41 22 Jul 2026

TradingView Market update Main company 🇺🇸 United States

Price to book forward of Atara Biotherapeutics Inc – SWB:AT20

This article provides financial data for Atara Biotherapeutics Inc (SWB:AT20) on the Stuttgart Stock Exchange, specifically focusing on its price to book forward ratio. It highlights that the market is currently closed with no trades. The content is primarily a data presentation with minimal …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

23:40 22 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Enterprise value to revenue forward of Atara Biotherapeutics Inc – SWB:AT20

This article provides financial information for Atara Biotherapeutics Inc (SWB:AT20), specifically focusing on its enterprise value to revenue forward. It notes that the market for AT20 was closed with no trades. The content also mentions that financial data is provided by ICE Data Services …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

13:09 22 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Dynatrace Schedules Aug. 5 Call to Discuss Quarterly Results

Dynatrace (NYSE: DT) announced it will report its first-quarter fiscal year 2027 financial results on August 5, 2026, before U.S. financial markets open. The company will host a conference call and live webcast at 8:00 a.m. Eastern Time to discuss these results and its …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

13:00 22 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Dynatrace to Report First Quarter Fiscal Year 2027 Financial Results

BOSTON, July 22, 2026--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced that it will report financial results for its first quarter of fiscal year 2027 ended June 30, 2026 before the U.S. financial markets open on August 5, 2026. In conjunction …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

09:09 22 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Bank of New York Mellon Corp Sells 101,543 Shares of Dynatrace, Inc. $DT

Bank of New York Mellon Corp decreased its stake in Dynatrace, Inc. by 4.3% in the first quarter, selling over 101,000 shares but still retaining a significant holding valued at about $82.8 million. This comes as Dynatrace reported stronger-than-expected quarterly earnings and revenue growth. …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

07:15 22 Jul 2026

Market source Earnings Main company 🇺🇸 United States

Dynatrace (DT) Stock Drops Despite Market Gains: Important Facts to Note

Dynatrace (DT) shares dropped by 4.16% despite overall market gains, closing at $42.85. The company showed a 10.5% gain over the previous month, outperforming its sector. Upcoming earnings predict a 7.14% EPS growth and 15.07% revenue increase.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

22:26 21 Jul 2026

Quiver Quantitative Earnings Main company 🇺🇸 United States

Dynatrace slides as software peers weaken and no fresh company catalyst emerges

Dynatrace (DT) shares dropped 4.7% due to broad weakness in the software sector and profit-taking, rather than any new negative company announcement. Peer companies in cloud and observability software also traded lower, and Dynatrace's most recent financial update in May showed positive growth expectations …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

13:41 21 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

Dynatrace Is Maintained at Buy by Jefferies

Jefferies has reiterated its Buy rating on Dynatrace (NYSE:DT). This decision was based on a comprehensive analysis, which suggests a positive outlook for the company's stock.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

07:41 21 Jul 2026

Bitget Earnings Main company 🇺🇸 United States

DYNATRACE, INC. : OPPENHEIMER RAISES TARGET PRICE TO $55 FROM $45

Oppenheimer has increased its target price for Dynatrace, Inc. (DT.N) to $55 from $45. This adjustment indicates a more optimistic outlook by the firm on Dynatrace's future stock performance. The report was published by Reuters through Bitget News.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

21:11 20 Jul 2026

Moomoo Earnings Main company 🇺🇸 United States

Dynatrace Seen Building Toward Long-Term Financial Targets, Oppenheimer Says

Oppenheimer analysts believe Dynatrace is making progress towards its long-term financial goals, citing positive trends in its business. The report highlights the company's strong performance and strategic initiatives that are expected to contribute to future growth. This optimistic outlook suggests that Dynatrace is well-positioned …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

07:10 18 Jul 2026

Stock Traders Daily Guidance Main company 🇺🇸 United States

(DT) and the Role of Price-Sensitive Allocations

This article analyzes Dynatrace Inc. (NYSE: DT), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It identifies no resistance levels above the current price, suggesting compelling upside potential. The report provides three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

22:10 17 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Dynatrace (NYSE: DT) CAO vests 1,323 RSUs; now holds 35,457 shares

Dynatrace's SVP and Chief Accounting Officer, Daniel S. Yates, reported the vesting of 1,323 Restricted Stock Units (RSUs) on July 15, 2026. After withholding 389 shares for tax obligations at $45.17 per share, Yates now directly holds 35,457 common shares and has 6,612 RSUs …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

04:09 17 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Atara Biotherapeutics, Inc. (NASDAQ: ATRA) concerning potential corporate wrongdoing by its officers and/or directors. The firm is encouraging investors who purchased Atara securities prior to May 20, 2024, and still hold them, to contact …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

14:41 16 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

Dynatrace Is Maintained at Overweight by Keybanc

Keybanc has reiterated its Overweight rating on Dynatrace (DT). The price target for Dynatrace was also maintained at $65.00 by Keybanc.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

14:40 16 Jul 2026

GuruFocus Analyst action Main company 🇺🇸 United States

DT Maintained by Keybanc -- Price Target Raised to $53.00

Keybanc has reiterated an "Overweight" rating for Dynatrace (DT) and increased its price target from $47.00 to $53.00, reflecting a positive outlook on the company's growth potential. Dynatrace is currently considered significantly undervalued according to GF Value™, with a GF Score™ of 85/100, indicating …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

13:40 16 Jul 2026

Seeking Alpha Earnings Main company 🇺🇸 United States

Datadog, Dynatrace, Rubrik, Snowflake see price target increases at KeyBanc (DDOG:NASDAQ)

KeyBanc Capital Markets increased price targets for Datadog, Dynatrace, Rubrik, and Snowflake ahead of their upcoming earnings reports. Datadog's target rose to $320 from $225, and Dynatrace's increased to $53 from $47.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

13:10 16 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) securities. The investigation focuses on whether Atara and its officers engaged in corporate wrongdoing, particularly for investors who purchased shares before May 20, 2024. The …

ATRA main company

Sharemaestro market context Trend signal active 52 weeks -34.4%

12:40 16 Jul 2026

marketscreener.com Analyst action Main company 🇺🇸 United States

RBC Raises Price Target on Dynatrace to $50 From $45, Keeps Outperform Rating

RBC Capital Markets has increased its price target for Dynatrace (NYSE: DT) shares to $50, up from the previous $45, while maintaining an Outperform rating on the stock. This adjustment reflects continued analyst confidence in the AI-powered observability platform company.

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

21:11 15 Jul 2026

01net Market update Main company 🇺🇸 United States

Dynatrace Named a Leader in the 2026 Gartner® Magic Quadrant™ for Observability Platforms for the 16th Time

Dynatrace has been recognized as a Leader in the 2026 Gartner Magic Quadrant for Observability Platforms for the 16th time. The company was evaluated among 19 vendors and acknowledged for its completeness of vision and ability to execute. Dynatrace emphasizes its AI-powered platform provides …

DT main company

Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7%

165 matching headlines